Skip to main content
SpringerLink
Log in

Basilar Branch Occlusion

  • Cerebrovascular Disease and Stroke
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

During the past few years, the branch syndromes have been ascribed to pontine lesions, and the development of neuroimaging techniques has renewed the interest in exploring their clinical–radiological correlation. Brain imaging via MRI has helped in the diagnosis and accurate localization of lesions. From classic studies it is now accepted that the pathogenic mechanism of lacunar pontine infarction (LPI) is perforating small arterial disease or microangiopathy caused by lipohyalinosis, whereas paramedian pontine infarction (PPI) are caused by paramedian or circumferential basilar branch disease due to atheromatous branch occlusion. The importance of basilar artery disease not only in severe posterior circulation infarcts but also in minor brainstem strokes is known from previous reports. The mechanism of PPI is probably local occlusion of the mouths of paramedian perforators through the atheromatous basilar artery (basilar branch occlusion). Infrequent basilar artery diseases such as dissection, aneurysm and hypoplasia, dolichoectatic basilar artery, embolism, or vasospasms are known to block the orifices of penetrating branch arteries and cause an infarct in the territory of the obstructed branches. An association between basilar artery branch disease and isolated pontine infarction exists; moreover, the enlargement of pontine lesion seems to be associated with neurologic worsening and fluctuating symptoms, but we know little about stroke mechanisms in patients with fluctuating symptoms and about the role of branch atherosclerotic disease. The treatment remains controversial, even in acute cases. Implementation of new neuroimaging techniques, such as high-resolution MRI, could be helpful in identifying pathogenetic mechanisms of isolated pontine infarction, thus improving therapeutic strategy and secondary prevention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Bassetti C, Bogousslavsky J, Barth A, Regli F. Paramedian pontine infarct: clinical–topographical correlation. Neurology. 1996;46:165–75.

    PubMed  CAS  Google Scholar 

  2. Fisher CM, Curry HB. Pure motor hemiplegia of vascular origin. Arch Neurol. 1965;13:30–44.

    PubMed  CAS  Google Scholar 

  3. Fisher CM, Caplan LR. Basilar artery branch occlusion: a cause of pontine infarction. Neurology. 1971;21:900–5.

    PubMed  CAS  Google Scholar 

  4. Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology. 1989;39:1246–50.

    PubMed  CAS  Google Scholar 

  5. Caplan L. Posterior circulation disease: clinical findings, diagnosis and management. In: Blackwell Science, editors. Penetrating branch artery and lacunar stroke. 1996. pp. 381–443.

  6. Caplan LR, Wityk RJ, Glass TA, Tapia J, et al. New England Medical Center posterior circulation registry. Ann Neurol. 2004;56:389–98.

    Article  PubMed  Google Scholar 

  7. Erro ME, Gállego J, Herrera M, Bermejo B. Isolated pontine infarcts: etiopathogenic mechanisms. Eur J Neurol. 2005;12:984–8.

    Article  PubMed  CAS  Google Scholar 

  8. Tatsumi S, Yamamoto T. An autopsied case of an apparent pontine branch atheromatous disease. Eur Neurol. 2010;63:184–5.

    Article  PubMed  Google Scholar 

  9. Bogousslavsky J, Regli F, Maeder P, et al. The etiology of posterior circulation infarcts: a prospective study using magnetic resonance imaging and magnetic resonance angiography. Neurology. 1993;43:1528–33.

    PubMed  CAS  Google Scholar 

  10. Kwon HM, Kim JH, Lim JS, et al. Basilar artery dolichoectasia is associated with paramedian pontine infarction. Cerebrovasc Dis. 2009;27:114–8.

    Article  PubMed  Google Scholar 

  11. Mayor S, Erro ME, Zazpe I, Gállego J. Pontine stroke due to vasospasm secondary to perimesencephalic subarachnoid hemorrhage. Neurologia. 2008;23:256–8.

    PubMed  CAS  Google Scholar 

  12. Mandava P, Bebensee A, Rawlings RR, Kent TA. Basilar artery aneurysm thrombosis. Neurology. 2002;59:1287.

    PubMed  Google Scholar 

  13. Zandio Amorena B, Erro Aguirre ME, Cabada T, Ayuso Blanco T. Cocaine-induced brain stem stroke associated to cranial midline destructive lesions. Neurologia. 2008;23:55–8.

    PubMed  CAS  Google Scholar 

  14. Kumral E, Bayülkem G, Evyapan D. Clinical spectrum of pontine infarction. Clinical-MRI correlations. J Neurol. 2002;249:1659–70.

    Article  PubMed  Google Scholar 

  15. Farrar J, Donnan GA. Capsular warning syndrome preceding pontine infarction. Stroke. 1993;24:762.

    PubMed  CAS  Google Scholar 

  16. Klein IF, Lavallée PC, Schouman-Claeys E, Amarenco P. High-resolution MRI identifies basilar artery plaques in paramedian pontine infarct. Neurology. 2005;64(3):551–2.

    PubMed  Google Scholar 

  17. Klein IF, Lavallée PC, Mazighi M, et al. Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke. 2010;41:1405–9.

    Article  PubMed  Google Scholar 

  18. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27:493–501.

    Article  PubMed  CAS  Google Scholar 

  19. Kirshner HS. Current issues in antiplatelet therapy for stroke prevention: the importance of stroke subtypes and differences between stroke and MI patients. J Neurol. 2010;257:1788–97.

    Article  PubMed  CAS  Google Scholar 

  20. US Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med. 2004;140:554–6.

    Google Scholar 

  21. Adams Jr HP. Secondary prevention of atherothrombotic events after ischemic stroke. Mayo Clin Proc. 2009;84:43–51.

    Article  PubMed  Google Scholar 

  22. Progress Collaborative Group. Randomised trial of a perindopril based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–41.

    Article  Google Scholar 

  23. Schrader J, Luders S, Kulschewski A, et al. Mortality and morbidity after stroke—eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke. 2005;36:1218–26.

    Article  PubMed  CAS  Google Scholar 

  24. Amarenco P, Goldstein LB, Szarek M, et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007;38:3198–204.

    Article  PubMed  CAS  Google Scholar 

  25. Amarenco P, Benavente O, Goldstein LB, Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators, et al. Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke. 2009;40:1405–9.

    Article  PubMed  CAS  Google Scholar 

  26. Martínez-Sánchez P, Rivera-Ordóñez C, et al. The beneficial effect of statins treatment by stroke subtype. Eur J Neurol. 2009;16:127–33.

    Article  PubMed  Google Scholar 

  27. Fuentes B, Martínez-Sánchez P, Díez-Tejedor E. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Cerebrovasc Dis. 2009;27 Suppl 1:126–33.

    Article  PubMed  CAS  Google Scholar 

  28. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–39.

    Article  Google Scholar 

  29. Hankey GJ, Eikelboom JW. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. Lancet Neurol. 2010;9:273–84.

    Article  PubMed  CAS  Google Scholar 

  30. Diener H, Bogousslavsky J, Brass L, et al. Acetylsalicylic acid on a background of clopidogrel in high-risk patients randomised after recent ischaemic stroke or transient ischaemic attack: the MATCH trial results. Lancet. 2004;364:331–4.

    Article  PubMed  CAS  Google Scholar 

  31. Bhatt D, Fox K, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706–17.

    Article  PubMed  CAS  Google Scholar 

  32. Diener HC, Darius H, Bertrand-Hardy JM, et al. Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). Int J Clin Pract. 2001;55:162–3.

    PubMed  CAS  Google Scholar 

  33. Sacco RL, Diener HC, Yusuf S, PROFESS Study Group, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238–51.

    Article  PubMed  CAS  Google Scholar 

  34. Guiu JM, Ferro JM, Alvarez Sabin J, et al. Comparison of Triflusal and Aspirin for prevention of vascular events in patients after cerebral infarction. The TACIP study: a randomized, double blind, multicenter study. Stroke. 2003;34:840–8.

    Article  Google Scholar 

  35. Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005;36:782–6.

    Article  PubMed  CAS  Google Scholar 

  36. Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345:1444–51.

    Article  PubMed  CAS  Google Scholar 

  37. Chimowitz MI, Lynn MJ, Howlett-Smith H, for the WASID investigators, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–16.

    Article  PubMed  CAS  Google Scholar 

  38. Muengtaweepongsa S, Singh NN, Cruz-Flores S. Pontine warning syndrome: case series and review of literature. J Stroke Cerebrovasc Dis. 2010;19:353–6.

    Article  PubMed  Google Scholar 

  39. Hacke W, Kaste M, Bluhmki E, ECASS Investigators, et al. Thrombolysis with alteplase 3–4.5 h after acute ischemic stroke. N Engl J Med. 2008;359:1317–29.

    Article  PubMed  CAS  Google Scholar 

  40. Cocho D, Belvis R, Marti-Fabregas J, Bravo Y, Aleu A, Pagonabarraga J, et al. Does thrombolysis benefit patients with lacunar syndrome? Eur Neurol. 2006;55:70–3.

    Article  PubMed  Google Scholar 

  41. Vivanco-Hidalgo RM, Rodriguez-Campello A, Ois A, et al. Thrombolysis in capsular warning syndrome. Cerebrovasc Dis. 2008;25:508–10.

    Article  PubMed  Google Scholar 

  42. Saposnik G, Noel de Tilly L, Caplan LR. Pontine warning syndrome. Arch Neurol. 2008;65:1375–7.

    Article  PubMed  Google Scholar 

  43. Smith EE, Abdullah AR, Petkovska I, et al. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke. 2005;36:2497–9.

    Article  PubMed  CAS  Google Scholar 

  44. Baumann CR, Baumgartner RW, Gandjour J, et al. Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms. Stroke. 2006;37:1332–3.

    Article  PubMed  Google Scholar 

  45. Lee SJ, Saver JL, Liebeskind DS, et al. Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts. Stroke. 2010;41:2587–91.

    Article  PubMed  CAS  Google Scholar 

  46. González Hernández A, Fabre Pi O, López Fernández JC, Díaz Nicolás S. Thrombolysis in capsular warning syndrome. Med Clin (Barc). 2010;134:612–3.

    Article  Google Scholar 

  47. Stenting vs. Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS) trial NCT00576693]. www.clinicaltrials.gov.

Download references

Disclosure

The authors report no potential conflicts of interest relevant to this article.

Author information

Authors and Affiliations

  1. Servicio de Neurología, Complejo Hospitalario de Navarra, C/ Irunlarrea 3, 31008, Pamplona Navarra, Spain

    Jaime Gállego Culleré MD, PhD & María Elena Erro Aguirre MD, PhD

Authors
  1. Jaime Gállego Culleré MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. María Elena Erro Aguirre MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaime Gállego Culleré MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gállego Culleré, J., Erro Aguirre, M.E. Basilar Branch Occlusion. Curr Treat Options Cardio Med 13, 247–260 (2011). https://doi.org/10.1007/s11936-011-0125-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-011-0125-x

Keywords

Search

Navigation